Surface Expression of Bcl-2 in Chronic Lymphocytic Leukemia and Other B-Cell Leukemias and Lymphomas Without a Breakpoint t(14;18)

Since its discovery in follicular lymphoma cells at the breakpoint t(14;18), Bcl-2 has been studied extensively in many basic and clinical science settings. Bcl-2 can locate as an integral mitochondrial membrane component, where its primary role is to block apoptosis by maintaining membrane integrity. Here we show that Bcl-2 also can position on the outer cell surface membrane of B cells from patients with chronic lymphocytic leukemia (B-CLL) and certain other leukemias that do not classically possess the chromosomal breakpoint t(14;18).Although low levels of Bcl-2 can be detected on the surface membrane of apparently healthy leukemic and normal B cells, expression of Bcl-2 correlates best with spontaneous or induced apoptosis. Notably, upon induction of apoptosis, B-CLL cells were much more efficient in upregulating surface Bcl-2 than normal B cells. It is not clear if this surface membrane expression is a passive consequence of the apoptotic process or an active attempt by the B cell to abort cell death by stabilizing the plasma membrane.

[1]  John Calvin Reed.  Bcl-2-family proteins and hematologic malignancies: history and future prospects. , 2008, Blood.

[2]  N. Danial,et al.  BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death , 2007, Clinical Cancer Research.

[3]  W. Xie,et al.  Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. , 2007, Neoplasia.

[4]  M. Nakayama,et al.  Revival of apoptotic cells that display early‐stage dynamic membrane blebbing , 2007, FEBS letters.

[5]  Guido Kroemer,et al.  Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.

[6]  D. Weisenburger,et al.  Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia , 2007, Cell.

[7]  Michael T. Certo,et al.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. , 2007, The Journal of clinical investigation.

[8]  G. Taglialatela,et al.  Bcl-2 Localized at the Nuclear Compartment Induces Apoptosis after Transient Overexpression* , 2006, Journal of Biological Chemistry.

[9]  E. Yang,et al.  BCL2 family in DNA damage and cell cycle control , 2006, Cell Death and Differentiation.

[10]  Y. Lerenthal,et al.  Proapoptotic BID Is an ATM Effector in the DNA-Damage Response , 2005, Cell.

[11]  Katia Basso,et al.  Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) , 2004, The Lancet.

[12]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[13]  S. R. Datta,et al.  BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis , 2003, Nature.

[14]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[15]  W. Telford,et al.  Translocation of cytoplasmic HSP70 onto the surface of EL‐4 cells during apoptosis , 2002, Cell proliferation.

[16]  G. Tortora,et al.  Inhibition of bcl-2 as cancer therapy. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  P. Circosta,et al.  MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. , 1999, Leukemia research.

[18]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[19]  M. McNiven,et al.  The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing. , 1998, Journal of cell science.

[20]  J. B. Hutchins,et al.  Bcl‐2 Protects Isolated Plasma and Mitochondrial Membranes Against Lipid Peroxidation Induced by Hydrogen Peroxide and Amyloid β‐Peptide , 1998, Journal of neurochemistry.

[21]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[22]  G. Pizzolo,et al.  In leukaemic CD5+ B cells the expression of BCL‐2 gene family is shifted toward protection from apoptosis , 1996, British journal of haematology.

[23]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[24]  E. Newcomb,et al.  Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. , 1994, Blood.

[25]  Z. Oltvai,et al.  Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. , 1994, The Journal of biological chemistry.

[26]  N. Oyaizu,et al.  Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes. , 1994, Clinical immunology and immunopathology.

[27]  S. Korsmeyer,et al.  Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. , 1993, The Journal of biological chemistry.

[28]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[29]  John Calvin Reed,et al.  Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.

[30]  L. Herzenberg,et al.  The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. , 1992, International immunology.

[31]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[32]  M. Cleary,et al.  The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation , 1989, Molecular and cellular biology.

[33]  C. Croce,et al.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.

[34]  D. Vaux,et al.  A chronology of cell death , 2004, Apoptosis.

[35]  G Fischer,et al.  Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. , 2003, Reviews of physiology, biochemistry and pharmacology.

[36]  K. Nakayama,et al.  Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis , 2003, Nature Cell Biology.

[37]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[38]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[39]  T. Kipps.  The CD5 B cell. , 1989, Advances in immunology.